We investigated the anti-tumor effects of Verbena officinalis extract on H22 tumor-bearing mice and its effect on immune function. Mice model of H22 solid tumor was established, the mice were divided into five groups and administered the extract, later, tumors were removed and inhibition rates were calculated; spleens were removed and spleen indices were calculated, and the sheep red blood cell-delayed-type hypersensitivity (SRBC-DTH) and the serum hemolysin level were determined. The Verbena officinalis extract had anti-tumor effect, with the inhibition rate reaching 38.78%, it also increased the spleen index to a certain extent, in addition, the changes in DTA and HA were not obvious compared with the model group. The Verbena officinalis extract had in vivo anti-tumor effect, while causing no damage on the immune function.
Introduction
Verbena officinalis is the dried aerial parts of Verbena officinalis L. and bought from Zaoyang City in Hubei province, which belongs to the Verbenaceae family (Chinese Pharmacopoeia Commission, 2010), it is mainly used for the treatment of abdominal mass, amenorrhea, dysmenorrhea, malaria, pharyngitis, carbuncles, edema, etc. The main chemical constituents of 
Materials and Methods

Drugs and Reagents
Verbena officinalis (Baidu Medical Co., Ltd.); cisplatin (Qilu Pharmaceutical Co., Ltd.); SRBC (sterile sheep blood, after defiberization, stored at a 4 o C refrigerator for later use).
Determination of Body Weight
Before and after the experiment, mice in each group were weighed and their body weights were recorded.
Determination of Tumor Inhibition Rate
24 h after the last administration, mice were sacrificed, tumors were peeled off and weighed, and the tumor inhibition rate was calculated according to the following formula. Tumor inhibition rate = (average tumor weight of control groupaverage tumor weight of experimental group) / average tumor weight of control group × 100%
Determination of Spleen Index
After the mice were sacrificed, their spleens were removed and weighed. The ratio between spleen weight (mg) and body weight (g) was taken as the spleen index.
Determination of Footpad Swelling (DTH) and Serum Hemolysin Level
Footpad swelling (DTH) was determined by the footpad swelling method (Cao et al., 2009 ): Fresh defibered sheep blood was washed with sterile normal saline for three times, and prepared as 2% SRBC, on the 3rd day of the experiment, 0.2 ml of the 2% SRBC was injected intraperitoneally to each mouse to cause immunization, on the 4th day after immunization, the thicknesses of left and right footpads were measured with a vernier caliper, and 20% SRBC (20 ul/mouse) was injected subcutaneously at the measured site to induce the attack, 24 h after the attack, thicknesses of left and right footpads were measured, each site was measured for three times and the average value was obtained. DTH degree was represented by difference in thickness of front and rear footpads (footpad swelling) before and after the attack.
Serum hemolysin level was determined by the micro-hemagglutination assay (Xue et al., 1995) . On the 3rd day of administration, each mouse was injected intraperitoneally with 0.2 ml of 2% SRBC, 24 h after the last administration, mice eyeballs were enucleated and blood was extracted, serum was obtained by centrifugation, and serum hemolysin level was determined on the U-shaped 96-well microplate, the highest serum dilution factor showing (++) agglutination was taken as the hemolysin titer.
Statistical Methods
The experimental data was analyzed using the SPSS 13.0 software. T-test was used for the comparison between two groups, and pairwise comparisons among groups were performed using the One-way analysis of variance (ANOVA).
Results
Effect of Verbena Officinalis Extract on Body Weight of Mice
The changes in body weights of mice before and after the experiment were as shown in Table 1 , body weights increased markedly in all of the experimental groups except for the cisplatin group, but the increases were all smaller compared with the model group, and the amounts of increase were generally negatively correlated with the dosage. http://dx.doi.org/10.4314/ajtcam.v10i3.19 
Effect of Verbena Officinalis Extract on Tumor Weight and Tumor Inhibition Rate
The results for the effect of Verbena officinalis extract on tumor weight and tumor inhibition rate were as shown in Table 2 , tumor weights between the model group and high-dose Verbena officinalis group had a very significant difference (P<0.01), tumor weights between the model group and medium-dose Verbena officinalis group also had a significant difference (P<0.05), moreover, the tumor inhibition rate for the high-dose group was greater than 30%, suggesting that the Verbena officinalis extract had an obvious inhibitory effect on H22 solid tumor in mice. Compared with the model group, tumor weight was also reduced in the low-dose Verbena officinalis group, but there was no significant difference. 
Effect of Verbena Officinalis Extract on Spleen Index of H22 Tumor-Bearing Mice
The effect of Verbena officinalis extract on spleen index of H22 tumor-bearing mice was as shown in Table 3 -3, compared with the model group, spleen indices of the high-and medium-dose Verbena officinalis groups were both increased, but the differences were not significant, suggesting that the Verbena officinalis extract had no significant effect on spleen index of tumor-bearing mice. 
Results of Determination of Footpad Swelling (DTH) and Serum Hemolysin Level
The effects of Verbena officinalis extract on footpad swelling (DTH) and serum hemolysin level of mice were as shown in Table 4 , compared with the model group, DTH in each group were increased, but the increase was not significant. HA content in the cisplatin group showed significant difference compared with the model group, while HA content in treatment groups showed no significant differences, indicating that the Verbena officinalis extract had no significant suppressive effects on delayed-type hypersensitivity response to SRBC and on antibody production against SRBC, Verbena officinalis could inhibit the tumor growth, while causing no apparent damage to the immune organs, cellular immunity and humoral immune functions. 
